Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-004888
Filing Date
2025-11-14
Accepted
2025-11-14 10:27:59
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5612
  Complete submission text file 0001172661-25-004888.txt   7743
Mailing Address 77 4TH AVENUE WALTHAM MA 02451
Business Address 77 4TH AVENUE WALTHAM MA 02451 781-663-6900
REVVITY, INC. (Subject) CIK: 0000031791 (see all company filings)

EIN.: 042052042 | State of Incorp.: MA | Fiscal Year End: 1229
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-18230 | Film No.: 251482332
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address 150 BLOOR STREET W SUITE 700 TORONTO A6 M5S 2X9
Business Address 150 BLOOR STREET W SUITE 700 TORONTO A6 M5S 2X9 416-963-9353
EdgePoint Investment Group Inc. (Filed by) CIK: 0001481669 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0331
Type: SCHEDULE 13G/A